share_log

Arcutis Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jennison Associates LLC(10.8%)

SEC announcement ·  Mar 6 23:33
Summary by Futu AI
On February 29, 2024, Jennison Associates LLC filed an amended Schedule 13G/A with the Securities and Exchange Commission, disclosing a 10.8% ownership stake in Arcutis Biotherapeutics, Inc., amounting to 12,128,533 shares. Jennison Associates, a Delaware-based investment adviser, reported this stake as a result of its advisory role to various investment companies and institutional clients. Prudential Financial, Inc., which owns Jennison Associates, may also be deemed to have influence over the voting and disposal of the shares held by Jennison's managed portfolios. The filing clarified that the shares were acquired in the ordinary course of business and not with the intent to change or influence the control of Arcutis Biotherapeutics. The statement also emphasized that no single client owns more than 5% of the class of securities, and the shares are not held for any purpose related to changing or influencing the control of the company.
On February 29, 2024, Jennison Associates LLC filed an amended Schedule 13G/A with the Securities and Exchange Commission, disclosing a 10.8% ownership stake in Arcutis Biotherapeutics, Inc., amounting to 12,128,533 shares. Jennison Associates, a Delaware-based investment adviser, reported this stake as a result of its advisory role to various investment companies and institutional clients. Prudential Financial, Inc., which owns Jennison Associates, may also be deemed to have influence over the voting and disposal of the shares held by Jennison's managed portfolios. The filing clarified that the shares were acquired in the ordinary course of business and not with the intent to change or influence the control of Arcutis Biotherapeutics. The statement also emphasized that no single client owns more than 5% of the class of securities, and the shares are not held for any purpose related to changing or influencing the control of the company.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.